Skip to main content

Angiogenesis and Vascular Malformations

  • Chapter
  • First Online:
Congenital Vascular Malformations

Abstract

The role of angiogenesis in the pathogenesis and progression of vascular malformations is not fully understood. It is clear that vascular malformations develop because of defective angiogenesis or vasculogenesis caused by somatic or germline mutations in the proteins that regulate this process. Once formed, both normal angiogenesis involved in growth and reproduction, and pathological angiogenesis, often a reaction to intervention or injury, have roles in progression and symptomatology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kulungowski AM, Hassanein AH, Nose V, Fishman SJ, Mulliken JB, Upton J, et al. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations. Plast Reconstr Surg. 2012;129(6):919e–24e.

    Article  CAS  PubMed  Google Scholar 

  2. Maclellan RA, Vivero MP, Purcell P, Kozakewich HP, DiVasta AD, Mulliken JB, et al. Expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014;133(3):344e–51e.

    Article  CAS  PubMed  Google Scholar 

  3. Choi EJ, Kim YH, Choe SW, Tak YG, Garrido-Martin EM, Chang M, et al. Enhanced responses to angiogenic cues underlie the pathogenesis of hereditary hemorrhagic telangiectasia 2. PLoS One. 2013;8(5):e63138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol. 2013;4(4):179–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Boscolo E, Limaye N, Huang L, Kang KT, Soblet J, Uebelhoer M, et al. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest. 2015;125(9):3491–504.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rangel-Castilla L, Russin JJ, Martinez-Del-Campo E, Soriano-Baron H, Spetzler RF, Nakaji P. Molecular and cellular biology of cerebral arteriovenous malformations: a review of current concepts and future trends in treatment. Neurosurg Focus. 2014;37(3):E1.

    Article  PubMed  Google Scholar 

  7. Choi EJ, Chen W, Jun K, Arthur HM, Young WL, Su H. Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia. PLoS One. 2014;9(2):e88511.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Murphy PA, Kim TN, Lu G, Bollen AW, Schaffer CB, Wang RA. Notch4 normalization reduces blood vessel size in arteriovenous malformations. Sci Transl Med. 2012;4(117):117 ra8.

    Article  Google Scholar 

  9. Lubeck BA, Lapinski PE, Bauler TJ, Oliver JA, Hughes ED, Saunders TL, et al. Blood vascular abnormalities in Rasa1(R780Q) knockin mice: implications for the pathogenesis of capillary malformation-arteriovenous malformation. Am J Pathol. 2014;184(12):3163–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Han S, Huang Y, Wang Z, Li Z, Qin X, Wu A. Increased rate of positive penicillin skin tests among patients with glioma: insights into the association between allergies and glioma risk. J Neurosurg. 2014;121(5):1176–84.

    Article  PubMed  Google Scholar 

  11. Lu L, Bischoff J, Mulliken JB, Bielenberg DR, Fishman SJ, Greene AK. Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations. Plast Reconstr Surg. 2011;128(4):260e–9e.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Azzopardi N, Dupuis-Girod S, Ternant D, Fargeton AE, Ginon I, Faure F, et al. Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. MAbs. 2015;7(3):630–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Neil JA, Li D, Stiefel MF, Hu YC. Symptomatic de novo arteriovenous malformation in an adult: case report and review of the literature. Surg Neurol Int. 2014;5:148.

    PubMed  PubMed Central  Google Scholar 

  14. Gao P, Chen Y, Lawton MT, Barbaro NM, Yang GY, Su H, et al. Evidence of endothelial progenitor cells in the human brain and spinal cord arteriovenous malformations. Neurosurgery. 2010;67(4):1029–35.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia E. Burrows MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Burrows, P.E. (2017). Angiogenesis and Vascular Malformations. In: Kim, YW., Lee, BB., Yakes, W., Do, YS. (eds) Congenital Vascular Malformations. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46709-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46709-1_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46708-4

  • Online ISBN: 978-3-662-46709-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics